SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-009398
Filing Date
2022-05-26
Accepted
2022-05-26 16:17:32
Documents
46
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 10-K bzyr-20220228x10k.htm   iXBRL 10-K 1155178
2 EX-31.1 bzyr-20220228xex31d1.htm EX-31.1 12224
3 EX-31.2 bzyr-20220228xex31d2.htm EX-31.2 12004
4 EX-32.1 bzyr-20220228xex32d1.htm EX-32.1 7331
5 EX-32.2 bzyr-20220228xex32d2.htm EX-32.2 7376
  Complete submission text file 0001558370-22-009398.txt   3505063

Data Files

Seq Description Document Type Size
6 EX-101.SCH bzyr-20220228.xsd EX-101.SCH 34290
7 EX-101.CAL bzyr-20220228_cal.xml EX-101.CAL 20776
8 EX-101.DEF bzyr-20220228_def.xml EX-101.DEF 93709
9 EX-101.LAB bzyr-20220228_lab.xml EX-101.LAB 253073
10 EX-101.PRE bzyr-20220228_pre.xml EX-101.PRE 173892
40 EXTRACTED XBRL INSTANCE DOCUMENT bzyr-20220228x10k_htm.xml XML 331191
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 22970286
SIC: 2835 In Vitro & In Vivo Diagnostic Substances